Apogee Therapeutics Inc (APGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||
| Net Income | -182,146 | -83,985 | -39,785 |
| Depreciation Amortization | -12,052 | -3,071 | N/A |
| Accounts payable and accrued liabilities | -1,072 | 1,613 | 418 |
| Other Working Capital | -2,002 | 6,105 | 9,815 |
| Other Operating Activity | 26,098 | 4,577 | 13,125 |
| Operating Cash Flow | $-171,174 | $-74,761 | $-16,427 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | -299,310 | -273,743 | N/A |
| PPE Investments | -1,152 | -167 | N/A |
| Investing Cash Flow | $-300,462 | $-273,910 | $N/A |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 495,109 | 315,391 | N/A |
| Other Financing Activity | 0 | 0 | 168,317 |
| Financing Cash Flow | $495,109 | $315,391 | $168,317 |
| Beginning Cash Position | 118,610 | 151,890 | N/A |
| End Cash Position | 142,083 | 118,610 | 151,890 |
| Net Cash Flow | $23,473 | $-33,280 | $151,890 |
| Free Cash Flow | |||
| Operating Cash Flow | -171,174 | -74,761 | -16,427 |
| Capital Expenditure | -1,152 | -167 | N/A |
| Free Cash Flow | -172,326 | -74,928 | -16,427 |